Sunshine Biopharma Inc. (SBFM) Form 10-Q Quarterly Reports
Sunshine Biopharma Inc. (SBFM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SBFM
CIK: 1402328
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: CO
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
M&K CPAS, PLLC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJonathan Robbins
Audit LocationThe Woodlands, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14C | 2026-10-14 | 2026-10-14 | PRELIMINARY INFORMATION STATEMENT | 0001683168-26-007847 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-13 | CURRENT REPORT | 0001683168-26-007845 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-14 | — | SCHEDULE 13G Filing | 0002063341-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0001649553-26-000116 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-08 | CURRENT REPORT | 0001683168-26-007758 | View SEC Doc Filr Page |
| 424B4 | 2026-10-09 | — | PROSPECTUS | 0001683168-26-007757 | View SEC Doc Filr Page |
| EFFECT | 2026-10-07 | — | EFFECT Filing | 9999999995-26-003179 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-05 | — | SCHEDULE 13G/A Filing | 0001094891-26-000296 | View SEC Doc Filr Page |
| S-1 | 2026-10-02 | — | FORM S-1 | 0001683168-26-007581 | View SEC Doc Filr Page |
| DEF 14C | 2026-09-28 | 2026-09-15 | DEFINITIVE INFORMATION STATEMENT | 0001683168-26-007435 | View SEC Doc Filr Page |
| DRS | 2026-09-24 | — | DRS Filing | 0001683168-26-007374 | View SEC Doc Filr Page |
| PRE 14C | 2026-09-16 | 2026-09-15 | PRELIMINARY PROXY | 0001683168-26-007195 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | FORM 8-K | 0001683168-26-007193 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-11 | FORM 8-K | 0001683168-26-007090 | View SEC Doc Filr Page |
| EFFECT | 2026-09-08 | — | EFFECT Filing | 9999999995-26-002914 | View SEC Doc Filr Page |
| 424B3 | 2026-09-08 | — | FORM 424B3 | 0001683168-26-007017 | View SEC Doc Filr Page |
| S-1 | 2026-08-28 | — | FORM S-1 | 0001683168-26-006779 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-25 | CURRENT REPORT | 0001683168-26-006777 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001079973-26-001125 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006340 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088834 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001683168-26-006206 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | FORM 8-K | 0001683168-26-005899 | View SEC Doc Filr Page |
| 424B5 | 2026-07-20 | — | PROSPECTUS SUPPLEMENT | 0001683168-26-005657 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | FORM 8-K | 0001683168-26-005656 | View SEC Doc Filr Page |